Accession Number:

ADA324416

Title:

The Effect of Intramedullary Polymethylmethacrylate and Autogenous Cancellous Bone on Healing of Frozen Segmental Allografts,

Descriptive Note:

Corporate Author:

WISCONSIN UNIV-MADISON SCHOOL OF VETERINARY MEDICINE

Report Date:

1997-02-01

Pagination or Media Count:

57.0

Abstract:

This study was designed to compare limb function, bone mineral density, periosteal callus, new bone, porosity, histology, and union of mid-diaphyseal segmental allografts of the femur stabilized with an interlocking nail ILN technique in a dog model. An in vivo study was performed to compare the effects of augmenting ILN fixation with the following ILN alone n, ILN plus intramedullary cement nc, ILN plus intramedullary cement and autogenous cancellous bone applied to the periosteal surface of the host-allograft junction ncp, ILN plus autogenous cancellous bone applied to the endosteal surface of the allograft ne, ILN plus autogenous cancellous bone applied to the periosteal surface of the host-allograft junction np, and ILN plus autogenous cancellous bone applied to the periosteal surface of the host-allograft junction and to the endosteal surface of the allograft npe. Following allograft implantation, the dogs were evaluated by radiography, dual energy X-ray absorptiometry, and force plate gait analysis from 0 to 24 weeks. Six months after allograft implantation, the dogs were euthanatized and the femora processed for analysis. There were no differences between treatments for limb function or bone mineral density. Callus area 4 weeks after surgery was greater along the lateral and cranial surfaces for treatments receiving periosteal cancellous bone P0.05. This was also evident along the caudal surface at 24 weeks P0.05. New bone within the allograft segment did not differ between treatments and was reduced compared to the host-allograft junctions P0.05. Histologic scores were greatest with treatments ncp and npe, listed above P0.05.

Subject Categories:

  • Anatomy and Physiology
  • Medicine and Medical Research

Distribution Statement:

APPROVED FOR PUBLIC RELEASE